appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
Company could not produce at its full capacity and could not export all orders. Moreover, the Company still had loss in exchange and the increase in cost of production. Please be informed Yours sincerely
manufacture Low Melting Fiber (LMF), with an annual capacity of 60,000 tonnes. LMF is commonly used as a binder fiber in core-sheath constructions to produce HVA applications for automotive and industrial
and took time to validate and eventually produce, therefore the company has to import the finished goods products for serving our protective coatings market. 3. The increasing of sells and
December 3, 2018 ago. The company would like to inform the progress of the remaining investment payment. To obtain the project to produce and sell tap water as follows: At present, on December 25, 2018, the
contract term, profitability of the contract remains the same. By the Standard, key changes compared to prior to 2019, are as follows: a) Device subsidy previously recognized as handset loss will be
fuel cell is an electrochemical device that combines hydrogen from natural gas and oxygen to produce electricity and heat. Fuel cells operate without combustion and it is considered as an option for a
expenses. In Q3/2017 the Company recorded the Baht 5.38 million After moving the production equipment to Prachinburi plant and utilizing the plant to produce the product, the production cost has been lowered
resulted in reallocation between sales and service revenue as well as marketing expenses while device subsidy is capitalized as contract assets and amortized against the service revenue over the customer
169 163 151 148 136 Blended 186 181 170 168 156 VOU (GB/data sub/month) Postpaid 6.7 7.5 8.3 9.2 10.9 Prepaid 4.1 5.4 6.2 7.0 8.2 Blended 4.7 5.9 6.7 7.6 8.9 Device Penetration 4G-handset penetration 39